🔎 Trials Near Me

Akèy › Liposarkom › Texas › Houston

Etid klinik pou Liposarkom nan Houston, TX

10 etid pou Liposarkom ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

Ap rekriteFaz 3
  • UT MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06422806

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Ap rekriteFaz 1/2
  • UT MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06498648

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Ap rekriteFaz 3
  • Investigative Site, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06881992

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Ap rekriteFaz 3
  • M D Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT04031677

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Ap rekriteFaz 1
  • UT MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT05711615

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Ap rekriteFaz 1/2
  • MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06975293

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Ap rekriteFaz 1
  • Texas Children's Hospital, Houston
Laj 1 a 21 · Tout sèks · Mizajou Aug 6, 2026 · NCT04715191

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Ap rekriteEtid obsèvasyon
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT07377747

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Ap rekriteFaz 1
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT06789172

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Ap rekriteFaz 1
  • Houston Methodist Hospital, Houston
Jiska laj 21 · Tout sèks · Mizajou Nov 3, 2025 · NCT06198296

Etid Liposarkom nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.